Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NN7L
|
|||
| Former ID |
DNCL002824
|
|||
| Drug Name |
AC 165198
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Phase 1 | [1] | |
| Company |
Amylin Pharmaceuticals; Biocon
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Measles virus Fusion glycoprotein (MeV F) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030890) | |||
| REF 2 | WO patent application no. 2013,1306,83, Xten conjugate compositions and methods of making same. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.